Automated Microscopic Urine Analyzers are the Next Generation & advanced instruments are awaited to foster the Urinalysis Market Growth

The Global Urinalysis Market is expected to reach over USD 2.14 billion by 2022, according to a new report by Grand View Research, Inc.

Automation is a key technological advancement affecting the efficiency and accuracy delivered by the new generation urinalysis devices and hence, the persistent demand for novel urinalysis instruments and consumables. For instance, the automatic bench-top and portable biochemical urine analyzers, automated urine sediment analyzers (Aution Hybrid AU-4050 from Arkray),and automated microscopic urine analyzers (Sysmex UF-1000i) are the next generation, advanced instruments is anticipated to foster the urinalysis market growth.

urinalysis-market.png

The introduction of CLIA-waived urine reagent strips such as CLIA-URS-10, CLIA-URS-10-3PROMO, and CLIA-URS-10-10 provide for an effective screening tool for rapid testing in urine analysis which are estimated to enhance the usage rates of urinalysis reagents thus accentuating the market growth over the forecast period.

The target population base for urinalysis market is increasing owing to, factors such as the rising prevalence of target diseases, misdiagnosis, and low awareness levels pertaining to urine analysis in low-income countries. High incidences of obesity coupled with hypertension, diabetes, and other chronic disorders foster the growth of the urinalysis market.

Browse Full Research Report on Urinalysis Market: http://www.grandviewresearch.com/industry-analysis/urinalysis-market

Further key findings from the study suggest:

  • Urinary Tract Infections (UTIs)dominated the application segment in 2014. The foremost factor responsible for its high share is the rising prevalence of UTIs, especially in females. However, diabetes is estimated to be the fastest growing application segment with a CAGR of over 10% during the forecast period owing to a surge in the demand for automated and user-friendly urinalysis products for long-term diabetes management.
  • Consumables held the largest share with revenue generation of over USD 1 million in 2014. The increasing usage of test strips and reagents for urinalysisis one of the major factors that are attributed to its large market share. However, the instrument segment is expected to witness the fastest growth with a CAGR of over 7%. Automation of instruments with improved efficiency and reliability is expected to govern this segment’s growth.
  • The home healthcare segment, on the other hand, is anticipated to grow at a substantial rate over 7.5%. The availability of technologically enabled point-of-care urinalysis systems, such as CLINITEK Status, is a key factor expected to reinforce the market growth.
  • North America dominated the overall urinalysis market with a revenue generation of over USD 540 million in 2014. The introduction of advanced urine analyzers by key market players in the U.S., favorable government initiatives ensuring the betterment of healthcare testing, and the high amount of healthcare spending in this region are the key factors attributing to the largest market share of this region.
  • Key players of this market include Roche Diagnostics, Alere, Inc., Siemens Healthcare, Bio-Rad, ARKRAY, Inc., Mindray, and Sysmex.
  • Market participants are constantly engaged in the introduction of novel diagnostic products in an attempt to ensure their sustainability and increase the penetration of their product portfolio. For instance, in June 2014, Roche launched a fully automated urine testing analyzer named Cobas 6500 with an objective to enhance staff safety and increase the result reliability.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the global urinalysis market on the basis of product, application, end-use, and region:

Global Urinalysis Product Outlook (Revenue, USD Million, 2015 – 2022)

  • Instruments
    • Biochemical urine analyzers
      • Automated biochemical analyzers
      • Semi-automated biochemical analyzers
    • Automated urine sediment analyzers
      • Microscopic urine analyzers
      • Flow-cytometric urine analyzers
    • Consumables
      • Dipsticks
      • Reagents
      • Disposables

Global Urinalysis Application Outlook (Revenue, USD Million, 2015 – 2022)

  • UTIs
  • Diabetes
  • Kidney Disease
  • Hypertension
  • Liver disease
  • Others

Global Urinalysis End-use Outlook (Revenue, USD Million, 2015 – 2022)

  • Hospitals
  • Clinical Laboratories
  • Home healthcare
  • Research and academics
  • Others

Urinalysis Regional Outlook (Revenue, USD Million, 2015 – 2022)

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • MEA
    • South Africa

Access Press Release of this Report:  http://www.grandviewresearch.com/press-release/global-urinalysis-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Growing Obesity, Hypertension and sedentary lifestyle is anticipated to driving Growth to the Wearable Medical Devices Market swiftly Till 2022

The Global Wearable Medical Device Market is expected to reach USD 27.8 billion by 2022, according to a new report by Grand View Research, Inc. Rising prevalence of conditions such as obesity and hypertension, as a result of sedentary lifestyle is anticipated to boost the demand for wearable medical devices. Moreover, increasing health awareness is further expected to augment the demand for these devices.

wearable-medical-devices-market.png

Additionally, growing incidences of chronic conditions, such as diabetes, which require round-the-clock monitoring, are expected to increase the demand for wearable technology. Technological innovation is projected to be vital for growth of this industry over the forecast period. Smart watches, smart bands, and smart clothing are anticipated to be the key areas for development. Increasing penetration of smart cellular phones is expected to assist growth of this technology. However, patient privacy and security concerns along with complexity in engineering are expected to impede growth of the industry.

Browse Full Research Report on Wearable Medical Device Market http://www.grandviewresearch.com/industry-analysis/wearable-medical-devices-market

Further key findings from the study suggest:

  • Diagnostic wearable medical devices held substantial share in 2014 owing to increasing usage in remote patient monitoring as well as home healthcare
  • Therapeutic wearable devices are anticipated to exhibit remunerative growth over the forecast period. Increasing penetration of products, such as insulin monitors, is assisting the growth of wearable equipment.
  • Diagnostic devices such as vital sign monitors are expected to witness lucrative growth over the forecast period. Rising incidences of chronic diseases are expected to boost the demand for this equipment.
  • Wearable medical devices have applications in sports & fitness monitoring, home healthcare, and remote patient monitoring. Home healthcare held significant shares of around 50.0% in 2014. Simplified usage of this equipment along with ability to synchronize with cellular phones as well as tablet devices assisted the growth of this segment.
  • On the contrary, remote patient monitoring is projected to exhibit growth rate of over 25.00% in the next seven years. Increasing geriatric population base coupled with demand for continuous monitoring is expected to fuel the growth.
  • Strap/clip/bracelet or watches held substantial shares of around 40.0% in 2014, and is expected to grow at a lucrative rate over the forecast period. Simplified engineering, aesthetically appealing products, and synchronization with mobile application are anticipated to drive this segment’s growth.
  • North America dominated the overall market with approximately 40.0% of shares. This can be attributed to increasing per capita income as well as rising healthcare spending, and advanced healthcare infrastructure and presence of OEM in this region.
  • Asia Pacific is projected to grow with a rapid rate of around 32.0% over the forecast period. Economic development coupled with improving healthcare systems is expected to help the industry grow in this region.
  • Key companies of the wearable medical devices industry include Fitbit Inc., Garmin, Vital Connect, Omron Corp., Sotera Wireless, Jawbone, Pebble Technology Corp., Basis Science, Inc., Withings, Intelesens Ltd., Covidien Plc, LifeWatch AG, Polar Electro, Philips Electronics, and Everist Genomics

Read Our Blog: http://www.grandviewresearch.com/press-release/global-wearable-medical-device-market

Grand View Research has segmented the global Wearable Medical Device Market on the basis of products and region:

Global Wearable Medical Devices Product Outlook (USD million), 2012 – 2022

  • Diagnostic devices
    • Vital sign monitors
      • Heart rate monitors
      • Activity monitors
      • Electrocardiographs
      • Pulse oximeters
      • Spirometers
      • Blood pressure monitors
      • Other devices
    • Sleep monitoring devices
      • Sleep trackers
      • Wrist actigraphs
      • Polysomnographs
      • Other devices
    • Electrocardiographs Fetal & Obstetric Devices
    • Neuromonitoring devices
      • Electroencephalographs (EEG)
      • Electromyographs (EMG)
      • Other devices
    • Therapeutic devices
      • Pain management device
        • Neurostimulation device
        • Other devices
      • Insulin monitoring device
        • Insulin pumps
        • Other devices
      • Rehabilitation device
        • Accelerometers
        • Sensing devices
        • Ultrasound platforms
        • Others
      • Respiratory therapy device
        • Ventilators
        • PAP
        • Portable oxygen concentrators
        • Other devices

Global Wearable Medical Devices Application Outlook (USD million), 2012 – 2022

  • Sports & Faintness
  • Remote Patient Monitoring
  • Home healthcare

Global Wearable Medical Devices Site Outlook (USD million), 2012 – 2022

  • Handheld
  • Headband
  • Strap, clip, bracelet and watches
  • Shoe sensors
  • Others

Wearable Medical Devices Region Outlook (USD million), 2012 – 2020

  • North America
    • US.
    • Mexico
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

Access Press Release  of this Report: http://www.grandviewresearch.com/press-release/global-wearable-medical-device-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Chronic Kidney Diseases (CKD) and Renal Failure Is Anticipated To Broaden The Scope For Market Growth Over The Forecast Period

The global Kidney Function Tests Market is expected to reach USD 1.9 billion by 2025, according to a new study by Grand View Research, Inc. The growing prevalence of Chronic Kidney Diseases (CKD) and renal failure is presumed to be responsible for the high urgency to use kidney function tests, which is anticipated tobroaden the scope for growth throughout the forecast period. In addition, expanding base of diabetic population, which is highly susceptible to the aforementioned diseases, is predicted to impel the demand further over the coming years. Consequently, resultant high sample volume will require high capability kidney function testing devices, which is believed to present the market with significant growth potential opportunities.

In addition, growing awareness with respect to diagnostic benefits associated with kidney function tests is also anticipated to be one of the high impact rendering drivers for this market. Emergence of technologically advanced products, such as automated analyzers, has led to refinement of current real-time point-of-care testing capabilities and, therefore, creates lucrative growth opportunities for the market. Furthermore, presence of public as well private healthcare organizations consistently striving to support diagnosis and management of CKD through a range of programs and initiatives is expected to create potential demand.

Browse Full Research Report on Kidney Function Tests Market: http://www.grandviewresearch.com/industry-analysis/kidney-function-tests-market

Further key findings from the study suggest:

  • Imaging tests are expected to exhibit lucrative CAGR owing to increasing adoption in wide array of clinical applications. The high penetration can be attributed to efficient renal function risk assessment due to abnormal results generated through other tests
  • Diagnostic laboratories are anticipated to exhibit lucrative CAGR during the forecast period owing to increasing preference for point-of-care testing by clinicians
  • In 2016, North America held a dominant share of the global kidney function tests market, as a consequence of increasing local presence of prominent companies undertaking competitive sustainability strategies
  • Asia Pacific is anticipated to grow at an exponential CAGR owing to unmet needs of patients, continuous infrastructural & technological upgradation, and increasing healthcare expenditure
  • Some key participants such as Abbott Laboratories; Merck Millipore; Alere, Inc.; and Quest Diagnostics are implementing various competitive strategies, such as new product development & frequent product approvals, to maintain their position in the market
  • For instance, in March 2015, metropolis announced the launch of a kidney function test, a PLA2R antibody test, that detects and evaluates intensity of membranous nephropathy

Read Our Blog: http://www.grandviewresearch.com/blog/kidney-function-tests-market-size-trends

Grand View Research has segmented the kidney function tests market on the basis of product, end use, and region:

Kidney Function Tests Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Dilution & Concentration Tests
  • Clearance Tests
  • Urine Tests
  • Imaging Tests

Kidney Function Tests End-Use Outlook (Revenue, USD Million, 2014 – 2025)

  • Hospitals
  • Diagnostic Laboratories
  • Academic Research Laboratories
  • Others

Kidney Function Tests Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

Access Press Release of this Report: http://www.grandviewresearch.com/press-release/global-kidney-function-tests-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Non-PVC IV Bags Market is expected to grow at a CAGR: 8.4% between 2014 To 2025: Grand View Research, Inc.

The global non-PVC IV bags market is expected to reach USD 2.29 billion by 2025, according to a new report by Grand View Research, Inc. Globally, increasing demand for safer medical packaging and strict regulations against usage of PVC are the key factors anticipated to boost the demand for non-PVC alternatives. Extensive research and developments for novel alternatives are expected to fuel the growth further.

germany-non-pvc-iv-bags-market.png

As per the current market scenario, usage of non-PVC IV bags is limited to fields such as chemotherapy and parenteral nutrition. With the introduction of different types of alternatives such as ethylene vinyl acetate and polypropylene, PVC packaging is anticipated to be replaced by non-PVC alternatives. These materials can be used for specific purposes such as cold/frozen storage and customized mixtures. The non-PVC packaging market is expected to witness lucrative growth during the forecast period owing to the versatility of applications.

Demand for non-PVC plastics is increasing in medical as well as non-medical industries owing to stricter regulations against their usage since their disposal can cause high level of pollution. The changing trend of using non-PVC materials provides a huge scope for growth, thus attracting manufacturers and investors to this market.

The demand for non-PVC IV bags is increasing in parenteral nutrition services. They also have high demand for multichambered bags; as the formulation differs from patient to patient. The scope for customized IV bags providers is anticipated to increase with the development of personalized therapeutic solutions.

To Request For Sample Copy Of This Report: http://www.grandviewresearch.com/industry-analysis/non-pvc-iv-bags-market

Further key findings from the report suggest:

  • Single chamber bags dominated the market by capturing 64.6% of the total market share in 2016. High usage in IV drips and other mixtures is a principal factor that can be attributed to the large share.
  • Ethylene vinyl acetate captured the largest share in 2016 and this dominance is expected to continue over the forecast period. Higher safety and utility of its usage in frozen mixtures including in blood banks are expected to have a high impact on the segment growth.
  • The demand for copolyester ether is expected to showcase highest growth during the forecast period due to advantages such as transparency, durability, and chemical resistance.
  • North America dominated the market and is expected to dominate throughout the forecast period. On the other hand, Asia Pacific is expected to showcase fastest growth, fueled by factors such as emergence of a large number of local players and increasing foreign direct investment.
  • Key players include ANGIPLAST PVT. LTD.; RENOLIT; Shanghai Xin Gen Eco-Technologies Co., Ltd; PolyCine GmbH; Jiangxi Sanxin Medtec Co., Ltd.; Kraton Corporation; Pfizer, Inc. (Hospira).; Baxter; and B. Braun Melsungen AG

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare\

Grand View Research has segmented the global non-PVC IV bags market on the basis of type, material, content type, and region:

Non-PVC IV Bags Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Single Chamber
  • Multichamber

Non-PVC IV Bags Material Outlook (Revenue, USD Million, 2014 – 2025)

  • Ethylene Vinyle Acetate
  • Polypropylene
  • Copolyester ether
  • Others

Non-PVC IV Bags Content Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Frozen Mixture
  • Liquid Mixture

Non-PVC IV Bags Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Access Press Release Of This Report: http://www.grandviewresearch.com/press-release/global-non-pvc-iv-bags-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Long Term Care Market is expected to boom owing to the increasing awareness of about the Home Healthcare Facilities and Medical Coverage

The global Long Term Care (LTC) Market is expected to reach USD 1,109 billion by 2024, according to a new report by Grand View Research, Inc. The market is expected to boom owing to the increasing awareness of people about the different home healthcare facilities, the increasing medical coverage for home healthcare, and the increasing aging population.

biometric-sensor-market.png

In October 2015, there were around 12 million people receiving home healthcare and the number is expected to increase dramatically. Moreover, according to the U.S. Census Bureau, the population aged 65 and older is expected to reach 84 million by 2050 as against 43.1 million in 2012. Moreover, there has been a shift to in-home care from long term care. The nursing homes have shrunk by 350 over the past six years, while the in-home nursing programs have doubled.

To Request for Sample Copy of this report: http://www.grandviewresearch.com/industry-analysis/long-term-care-services-market

Further key findings from the study suggest:

  • In 2015, the home healthcare dominated the market owing to the increasing awareness regarding home healthcare facilities, the cost savings offered by them as compared to hospital stays or nursing homes, and proactive health monitoring. Home healthcare is booming in the developing countries owing to the increasing need for geriatric care, double income households, and social changes. India has many home healthcare startups such as Health Care at Home, Zoctr, Vatsalya, Care24, Zozz, Life Circle Health Services, Healers at Home, and the Nightingales.
  • The hospice care is the fastest growing market owing to the increasing incidence rates of Alzheimer’s and dementia and an increase in the post-hospital care. Moreover, the coverage offered by both the Medicaid and private insurers has relieved the residents from the out-of-pocket payments that have to be borne by them. According to the Hospice Association of America, Medicaid pays USD 601 per day for the inpatient hospice care and USD 789 for 24-hour home care. Moreover, in August 2013, the Palliative Care and Hospice Education and Training Act provided a grant of USD 50 million for the training of doctors and allocating awards for educators in the field.
  • North America dominated the market in 2015. The market for long term care services is majorly driven by the increasing aging population, awareness about the advantages of home healthcare services, and the government support. Around 13% of the people in the U.S. are 65 years or above. By 2050, it is expected that one in five Americans would be at least 65 years of age.
  • Asia Pacific is the fastest growing market owing to the increasing rates of chronic diseases, the increasing disposable incomes, and decreasing working population. For instance, in China, the one-child policy has eventually decreased the working population as compared to the older population. In May 2016, MyCareLine raised USD 526,000 for its alliance with Hoffman World. The Spanish Company provides Hoffman methodology of rehabilitation. The method is commercial in Latin America and Europe. In India, Portea is one of the market leaders in the home healthcare industry. In September 2015, Portea raised USD 37.5 million for investing in better home healthcare facilities.
  • Industry players are continuously investing on expanding and revamping their existing facilities. For instance, in February 2016, Sunrise Senior Living, Inc. started a new facility joining its existing 41 Sunrise communities. The new facility will offer memory care programming, assisted living services, and support to residents in the early stage of memory loss.
  • Major market players are Brookdale Senior Living, Inc., Sunrise Senior Living, Inc., Emeritus Corporation, Atria Senior Living Group, Extendicare, Inc., Gentiva Health Services, Inc., Senior Care Centers of America, Kindred Healthcare, Inc., Genesis Healthcare Corp., and Home Instead Senior Care, Inc.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the global Long Term Care (LTC) market on the basis of service and region:           

Global Long Term Care (LTC) Service Outlook (Revenue, USD Billion, 2013 – 2024)

  • Home Healthcare
  • Hospice
  • Nursing Care
  • Assisted Living Facilities

Global Long Term Care (LTC) Regional Outlook (Revenue, USD Billion, 2013 – 2024)

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • India
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access Press Release of this Report: http://www.grandviewresearch.com/press-release/global-long-term-care-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Healthcare Biometrics Market is estimated to witness a CAGR of 24.1% over the forecast period

The global healthcare biometrics market is expected to reach USD 11.7 billion by 2024, according to a new report by Grand View Research, Inc. The demand for biometric systems in the healthcare market is expected to surge due to the rising cases of medical identity thefts, the most predominant form of healthcare fraud jeopardizing patient health, and the resultant government initiatives favoring digitalization of healthcare systems.

biometrics-in-healthcare-market.png

Associated benefits, such as data protection, elimination of the need of physical supervision, advanced security protocols, and strengthened patient trust & reliability, are certain vital impact rendering factors propelling the growth of these systems in the healthcare industry.

Also, establishment of federal laws, such as the Electronic Protected Health Information and Health Insurance Portability and Accountability acts are expected to propel the demand for these advanced biometric systems.

To Request A Sample Copy Of This Report: http://www.grandviewresearch.com/industry-analysis/biometrics-in-healthcare-market

Further key findings from the study suggest:

  • Based on technology, the healthcare biometrics market has been fragmented into face recognition, fingerprint analysis, iris recognition, vein recognition, palm geometry recognition, behavioral recognition, and others. Technologies such as DNA analysis and retina scanning-based solutions are expected to witness the fastest growth over the forecast period.
  • The other technologies segment is anticipated to grow at a CAGR of about 27.0%, which is attributable to the rapid development of DNA-based recognition systems and their incorporation within the healthcare field
  • The behavioral recognition technology is further classified into voice recognition, signature recognition, and others. The voice recognition segment is expected to witness lucrative growth over the forecast period due mainly to the technology advancements comprising miniaturization and greater processing power.
  • Systems with the ability to identify voice prints are being developed, for instance, Amerigroup Community Care of Florida aims to acquire a voice biometric solution for its Indian policy holders to overcome security lapses in telephonic communication
  • Based on region, North America is expected to dominate the market whereas Asia Pacific is anticipated to witness the fastest growth over the forecast period. The growth drivers in both these regions are similar, however, the presence of well-established infrastructure and digitalized platforms in North America are responsible for the high market share. By 2024, the Asia Pacific region is expected to contribute to over 20.0% of the revenue.
  • Some of the major industry players include BIO-key International, NEC Corporation, Imprivata, Inc., Fujitsu, Crossmatch, Suprema, 3M, HID Biometric, and MorphoTrust. New product launches and rising R&D efforts directed toward technology refinements by these companies will be witnessed over the forecast period.
  • Imprivata, Inc., approved the certification of their palm scan-based biometric platform PatientSecure, developed as a kiosk center whereby patients may identify themselves and register an appointment for one or more of the services offered at the respective healthcare facility. The approval was granted in July 2016 after it was showcased at the Healthcare Information and Management Systems Society conference.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the global healthcare biometrics market on the basis of technology and region.

Global Healthcare Biometrics Market by Technology (USD Million), 2013 – 2024

  • Face Recognition
  • Fingerprint Recognition
  • Iris Recognition
  • Vein Recognition
  • Palm Geometry Recognition
  • Behavioral Recognition
    • By technology
      • Signature recognition
      • Voice recognition
      • Others
    • By Type
      • Single factor authentication
      • Multi-factor authentication
      • Multi-modal authentication
    • Others

Healthcare Biometrics Market by Region (USD Million), 2013 – 2024

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

Access Press Release of this Report: http://www.grandviewresearch.com/press-release/global-biometrics-in-healthcare-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Histology & Cytology Market is Going To Reach $26.9 Billion By 2025: Grand View Research, Inc.

The global histology and cytology market size is expected to reach USD 26.9 Billion by 2025, according to a new report by Grand View Research, Inc. Globally, the increasing incidence of cancer and growing adoption of cytological tests due to its less invasive nature as compared to biopsy & higher reliability are likely to drive the market during the forecast period.

us-cytology-market.png

Furthermore, rising well-equipped clinical laboratories in developing countries and favorable reimbursement for cancer screening and laboratory tests are likely to positively affect the market growth. Advancements in the cytology and histology save the time for pathologists, hence this makes the service more cost-effective.

Cytology was the largest segment in the histology and cytology market in 2016 and is expected to maintain its dominance during the forecast period due to the recent entry of various tests for cytological testing and advantages over histology such as faster analysis and economical technique.

Cytology is further segmented into cervical, breast, and other cancers based on its application. Cervical cancer segment dominated in 2016 due to higher incidence and growing demand of test for the cervical cancer screening. Furthermore, breast cancer was considered as the second largest segment due to rising awareness about breast cancer screening in emerging countries.

To Request for Sample Copy of this report: http://www.grandviewresearch.com/industry-analysis/histology-and-cytology-market

Further Key Findings From the Report Suggest:

  • Rising incidence of cancer and growing investment by players are expected to propel growth at the fastest rate with a CAGR of 13.5% from 2017 to 2025
  • Cytology testing segment dominated in 2016 and is estimated to account for majority of the share by 2025.
  • Cytological testing for cervix is the largest contributing segment of the market. This can be attributed to high incidence and more adoption of the test for cervix screening.
  • The U.S. market was the largest in 2016 and is expected to maintain its dominance during forecast period due to higher awareness about screening and higher healthcare expenditure as compared to the developing countries.
  • In February 2014, Roche launched a new test for cervical cancer screening, Automated CINtec PLUS cytology test, which improves the detection of cervical precancer.
  • The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to growing investment by several clinics in the region, growing healthcare expenditure, and increasing adoption of screening tests.
  • Some of the key players operating are Abbott Laboratories; Becton, Dickinson and Company; F. Hoffmann-La Roche Ltd.; Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo Fisher Scientific, Inc.; and Trivitron Healthcare.

Read Our Blog: http://www.grandviewresearch.com/blog/histology-cytology-market-size-share

Grand View Research has segmented the global histology and cytology market on the basis of type of examination and region:

Type of Examination Outlook (Revenue, USD Million, 2014 – 2025)

  • Cytology
  • Cervical Cancer
  • Breast Cancer
  • Other Players
  • Histology

Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Central & South America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Access Press Release of this Report: http://www.grandviewresearch.com/press-release/global-histology-cytology-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com